The pharmaceutical industry was a flagship, particularly in Quebec and Canada, until the 2000s, when the Liberal government under Paul Martin suspended Technology Partnerships Canada on risk sharing. Another program was also abolished by Mr. Harper's Conservative government.
Should the government invest in similar programs to provide confidence and predictability to the pharmaceutical industry?